Igal Louria-Hayon

Direttore Tecnico/Scientifico/R&S presso RAPHAEL PHARMACEUTICAL INC.

Patrimonio netto: 2 M $ in data 31/05/2024

51 anni

Electronic Technology

Profilo

Igal Louria-Hayon is currently the Scientific Director-Medical Cannabis Research at Rambam Health Care Campus and the Director & Chief Technology Officer at Raphael Pharmaceutical, Inc. He previously worked as the Chief Technology Officer & Chief Scientist at Easy Energy, Inc. and as the Head-Leukemia & Immunotherapy Research Laboratory at Clinical Research Institute (Israel).

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
RAPHAEL PHARMACEUTICAL INC 5.35%	09/05/2024	999 000 ( 5.35% )	2 M $	31/05/2024

Posizioni attive di Igal Louria-Hayon

Società	Posizione	Inizio
RAPHAEL PHARMACEUTICAL INC.	Direttore Tecnico/Scientifico/R&S	27/09/2021
Rambam Health Care Campus	Corporate Officer/Principal	-

Tutte le posizioni attive di Igal Louria-Hayon

Precedenti posizioni note di Igal Louria-Hayon

Società	Posizione	Fine
Clinical Research Institute (Israel)	Corporate Officer/Principal	-
Easy Energy, Inc. Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel.	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Igal Louria-Hayon

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Igal Louria-Hayon

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Easy Energy, Inc. Easy Energy, Inc. Electronic Production EquipmentElectronic Technology Easy Energy, Inc. operates as a pharmaceutical drug research and development company. It focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil. The company was founded on May 17, 2007 and is headquartered in Tel Aviv-Jaffa, Israel.	Electronic Technology
Raphael Pharmaceutical, Inc.
Rambam Health Care Campus
Clinical Research Institute (Israel)

Vedi le connessioni aziendali

Borsa valori
Insiders
Igal Louria-Hayon